EB-1A for Bangladeshi Nationals

USCIS I-140 petition data for Bangladesh nationals (FY2025 Q4 (Jul-Sep 2025)).

54 I-140 petitions 15 approved #11 by volume
View Dashboard

USCIS I-140 Data

Bangladesh I-140 Petition Statistics

USCIS EB-1A petition data for Bangladesh nationals. FY2025 Q4 (Jul-Sep 2025).

I-140 Receipts

54

0.4% of all

I-140 Approvals

15

of 4,636 total

Volume Rank

#11

by I-140 receipts

Source: USCIS I-140 Performance Data, FY2025 Q4 (Jul-Sep 2025). Receipts and approvals for the reporting quarter.

Wait Time Estimator

Estimate Your Green Card Timeline

Enter your priority date and country to get a personalized estimate based on average DOS Final Action Date advancement over the last 12 months.

EB-1

Sources: I-140/I-485 ranges from USCIS Processing Times, backlog advancement averaged over last 12 DOS Visa Bulletins. Estimates only.

Find Bangladeshi EB-1A Cases

Browse real petition decisions and case studies from Bangladesh, or join the waitlist to get notified when personalized case matching launches.

Country Comparison

USCIS I-140 data, FY2025 Q4 (Jul-Sep 2025)

CountryReceiptsApprovals
Grand Total 7,4642,331
China 1,840460
India 1,613598
Bangladesh (current)5415
Case Data Insights

We analyzed 8 publicly available EB-1A petition decisions involving Bangladesh nationals. Of these, 75% were approved or sustained, 1 denied, and 1 remanded for further review. These cases span 5 industries and 3 job titles. Explore the charts below to see how decision outcomes have trended over time and which industries and roles have the highest success rates.

Decision Trends

0232024-082024-102024-122025-022025-042025-062025-082025-102025-12
Approved
Remanded
Denied

Top Industries

Biotechnology 3
Performing Arts 2
Information Technology 1
Nanotechnology 1
Renewable Energy 1

Top Job Titles

Research Assistant 3
Musician 2
Postdoctoral Researcher 1

Policy Updates

Bangladesh View all
Feb 2026 info Executive Order
Protecting the National Security and Welfare of the United States and its Citizens from Criminal Actors and Other Public Safety Threats

Applicants from Bangladesh may see more thorough reviews of their criminal history as DHS implements the executive order's mandate to maximize record access for screening purposes.

vettingsecurity_screening
Jan 2026 info USCIS Alert
USCIS to Increase Premium Processing Fees

Bangladeshi professionals will see a rise in the cost of premium processing for their I-140 petitions. This adjustment reflects USCIS's updated fee schedule for 2024.

fee-increaseexpedited-service
Dec 2025 info USCIS Alert
USCIS Clarifies Requirements for Professional Athletes

The policy update ensures that athletes from Bangladesh have the same clarity as those from larger sporting nations. It helps in identifying which specific types of evidence, such as national awards, will satisfy USCIS requirements.

visa-processing
Dec 2025 info USCIS Memo
USCIS Increases Screening, Vetting of Aliens Working in U.S.

Applicants from Bangladesh will see a more rigorous vetting process for their EB-1A petitions, requiring more substantial proof of their sustained national or international acclaim.

processing-timeRFE
Nov 2025 info USCIS Alert
USCIS Announces FY 2026 Inflation Increase for Certain Immigration-Related Fees

Applicants from Bangladesh will see an increase in the cost of filing for an EB-1A visa. As there is no specific backlog for Bangladesh in this category, the impact is limited to the fee amount.

filing feesinflation

Frequently Asked Questions

At a Glance

USCIS Official Data

I-140 Receipts 54
I-140 Rank #11 of 191

Scraped Case Data

Decisions 8
Success Rate 75%
Country Share 0.9%
Approved / Sustained 6
Denied / Dismissed 1
Top Industry Biotechnology
Top Job Title Research Assistant

Recent Decisions

View all

Research Assistant

Information Technology · Bangladesh

WeGreened approved
Massachusetts 425 days 2026-01-26
The petition was approved based on a track record of 1,149 citations and 70 peer-review instances, demonstrating professional trust and field-wide reliance. The petitioner authored 5 journal articles, 2 conference papers, and 1 book chapter, all peer-reviewed. Evidence of major research funding from the U.S. National Science Foundation and the Singapore National Research Foundation further validated the work's impact.
View Case

Others

Biotechnology · Bangladesh

WeGreened rfe approved
New York 100 days 2026-01-13
Approval was based on a robust record of 74 peer-reviewed journal articles and 4 preprints with 1,777 citations, demonstrating field-wide influence. The petitioner also completed at least 40 peer reviews, signifying recognized authority. Additionally, the work attracted support from major U.S. research sponsors and state-level departments.
View Case

Research Assistant

Renewable Energy · Bangladesh

WeGreened approved
North Carolina 45 days 2025-09-02
The petition satisfied EB-1A criteria through a record of 19 journal articles and 20 conference papers with 1,297 citations. The petitioner also demonstrated authority in the field by completing at least 130 peer reviews for respected journals. These metrics established the petitioner as being among the small percentage at the top of the field.
View Case

Research Assistant

Nanotechnology · Bangladesh

WeGreened approved
29 days 2025-06-17
The petition was approved based on 46 peer-reviewed journal articles and over 1,400 citations with an h-index of 23. The petitioner demonstrated extraordinary ability through 115 peer review assignments for 36 leading journals. Additionally, 28 of his articles were ranked in the top 1%, 10%, or 20% of the most cited works in his field.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened approved
Massachusetts 14 days 2025-05-21
The petition was approved based on a scholarly portfolio of 15 peer-reviewed publications in top-tier journals like Nature Methods and PNAS, which garnered 254 citations. The petitioner demonstrated professional standing through over 18 peer reviews for high-impact journals and service on editorial boards. Additionally, the research attracted funding from prestigious bodies including the NIH, NSF, and National Cancer Institute.
View Case